Animal models of lysosomal disease: An overview

Journal of Inherited Metabolic Disease

Volumn 21, Issue 5, 1998, Pages 540-547

  Suzuki, K ^a   Mansson J E ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ASPARTYLGLYCOSAMINURIA; BRAIN DEVELOPMENT; CONFERENCE PAPER; ENZYMOLOGY; ETHICS; GENE MUTATION; GENETIC RECOMBINATION; HUMAN; KNOCKOUT MOUSE; LIPIDOSIS; LYSOSOME STORAGE DISEASE; METABOLISM; METHODOLOGY; MOUSE MUTANT; MUCOPOLYSACCHARIDOSIS; NONHUMAN; PHENOTYPE; SPECIES DIFFERENCE; STEM CELL;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LYSOSOMAL STORAGE DISEASES; MICE; MICE, MUTANT STRAINS; PHENOTYPE;

EID: 0031849675     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005466905180     Document Type: Conference Paper

References (34)

1. Bradová V, Smíd F, Ulrich-Bott B, Roggendorf W, Paton BC, Harzer K (1993) Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease. Hum Genet 92: 143-152.
2. Capecchi MR (1994) Targeted gene replacement. Sci Am 270: 52-58.
3. Cohen-Tannoudji M, Marchand P, Akli S, et al (1995) Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease. Mammalian Genome 6: 844-849.
4. Fujita N, Suzuki K, Vanier MT, et al (1996) Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum Mol Genet 5: 711-725.
5. M1-ganglioside accumulation in mice defective in lysosomal acid β-galactosidase. Hum Mol Genet 6: 205-211.
6. Hoogerbrugge PM, Poorthuis BJHM, Romme AE, van de Kamp JJP, Wagemaker G, van Bekkum DW (1988a) Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse. J Clin Invest 81: 1790-1794.
7. Hoogerbrugge PM, Suzuki K, Suzuki K, et al (1988b) Donor derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science 239: 1035-1038.
8. Horinouchi K, Erlich S, Perl DP, et al (1995) Acid sphinogomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nature Genetic 10: 288-293.
9. Ichioka T, Kishimoto Y, Brennan S, Santos GW, Yeager AM (1987) Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twticher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides. Proc Natl Acad Sci USA 84: 4259-4263.
10. Köster A, Saftig P, Matzner U, von Figura K, Peters C, Pohlmann R (1993) Targeted disruption of the M(r) 46 000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins. EMBO J 12: 5219-5223.
11. Kyle JW, Birkenmeier EH, Gwynn B, et al (1990) Correction of murine mucopolysaccharidosis VII by a human β-glucuronidase transgene. Proc Natl Acad Sci USA 87: 3914-3918.
12. Ludwig T, Ovitt CE, Bauer U, et al (1993) Targeted disruption of the mouse cation-dependent mannose 6-phosphate receptor results in partial missorting of multiple lysosomal enzymes. EMBO J 12: 5225-5235.
13. Ludwig T, Munier-Lehmann H, Bauer U, Hollinshead M, Ovitt C, Lobel P, Hoflack B (1994) Differential sorting of lysosomal enzymes in mannose 6-phosphate receptor-deficient fibroblasts. EMBO J 13: 3230-3437.
14. Luzi P, Rafi MA, Victoria T, Baskin GB, Wenger DA (1997) Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate. Genomics 42: 319-324.
15. Matsuda J, Suzuki O, Oshima A, Ogura A, Naiki M, Suzuki Y (1997) Neurological manifestations of knockout mice with β-galactosidase deficiency. Brain Dev 19: 19-20.
16. Matsushima GK, Taniike M, Glimcher LH, et al (1994) Absence of MHC class II molecules reduces CNS demyelination, microglial; macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell 78: 645-656.
17. Otterbach B, Stoffel W (1995) Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81: 1053-1061.
18. Phaneuf D, Wakamatsu N, Huang JQ, et al (1996) Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 5: 1-14.
19. Platt FM, Neises GR, Reinkensmeier G, et al (1997) Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science 276: 428-431.
20. Pohlmann R, Wendland M, Boeker C, von Figura K (1995) The two mannose 6-phosphate receptors transport distinct complements of lysosomal proteins. J Biol Chem 270: 27311-27318.
21. Saftig P, Hartmann D, Lüllmann-Rauch R, et al (1997) Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system. J Biol Chem 272; 18628-18635.
22. Sands MS, Vogler C, Torrey A, et al (1997) Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation. J Clin Invest 99: 1596-1605.
23. Sango K, McDonald MP, Crawley JN, et al (1996) Mice lacking both subunits of lysosomal β-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nature Genetics 14: 348-352.
24. Suzuki K (1984) 'Authentic animal models' for biochemical studies of human genetic disease. In Arima M, Suzuki Y, Yabuuchi H, eds. Developmental Disabilities. Tokyo: Tokyo University Press, 129-138.
25. Suzuki K, Suzuki K (1995) The twitcher mouse: a model for Krabbe disease and for experimental therapies. Brain Pathol 5: 249-258.
26. Suzuki K, Proia RL, Suzuki K (1998) Mouse models of human lysosomal diseases. Brain Pathol, 8: 195-215.
27. Suzuki K, Sango K, Proia RL, Langaman C (1997) Mice deficient in all forms of lysosomal beta-hexosaminidase show mucopolysaccharidosis-like pathology. J Neuropathol Exp Neurol 56: 693-703.
28. Suzuki K, Vanier MT, Suzuki K (1998) Lysosomal disorders. In Popko B, ed. Mouse Models of Human Genetic Neurological Disease. New York: Plenum Press, in press.
29. Tanaka H, Suzuki K (1975) Lactosylceramide β-galactosidase in human sphingolipidoses: Evidence for two genetically distinct enzymes. J Biol Chem. 250: 2324-2332.
30. Tanaka H, Suzuki K (1977) Substrate specificities of the two genetically distinct human brain β-galactosidases. Brain Res 122: 325-335.
31. Yamanaka S, Johnson MD, Grinberg A, et al (1994) Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc Natl Acad Sci USA 91: 9975-9979.
32. Yeager AM, Brennan S, Tiffany C, Moser HW, Santos GW (1984) Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science 225: 1053-1054.
33. Yeager AM, Shinn C, Shinohara M, Pardoll DM (1993) Hematopoietic cell transplantation in the twitcher mouse: the effects of pretransplant conditioning with graded doses of busulfan. Transplantation 56: 185-190.
34. Zhou XY, Morreau H, Rottier R, et al (1995) Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes Dev 9: 2623-2634.